[Clinical and subclinical hyperthyroidism: two faces of the coin?]

Area of Science:

• Endocrinology
• Thyroidology
• Geriatric Medicine

Context:

• Hypothyroidism, both subclinical and overt, affects older adults, presenting with symptoms like fatigue and constipation.
• Distinguishing between subclinical and overt hypothyroidism is crucial for appropriate management in elderly patients.
• Common initial misdiagnoses include primary hypothyroidism, heart failure, hypertensive urgencies, and stroke.

Purpose:

• To compare the clinical characteristics, biochemical profiles, and levothyroxine (L-T4) treatment requirements in patients with subclinical versus overt hypothyroidism.
• To evaluate the efficacy of L-T4 therapy in normalizing thyroid-stimulating hormone (TSH) levels in these patient groups.
• To establish guidelines for initiating L-T4 therapy in subclinical hypothyroidism based on TSH levels, goiter, and thyroid antibodies.

Summary:

• A prospective study analyzed 23 subclinical and 45 overt hypothyroidism patients (mean age 68.3-70.3 years).
• Overt hypothyroidism showed significant changes in Free Thyroxine (fT4), T3, cholesterol, triglycerides, HDL-C, LDL-C, and TSH levels post-treatment, while subclinical hypothyroidism only showed TSH changes.
• Subclinical hypothyroidism required a significantly lower daily L-T4 dose (71.8 mcg) compared to overt hypothyroidism (107 mcg) for TSH normalization.
• Thyroid antibodies were more valuable as predictors than for diagnosis.

Impact:

• The findings support initiating L-T4 therapy in specific subclinical hypothyroidism cases (TSH ≥ 10 microU/ml, TSH > 5 with goiter, or positive antibodies).
• This research aids in optimizing levothyroxine dosing and treatment strategies for hypothyroidism in the elderly.
• Understanding these differences can improve patient outcomes and reduce healthcare costs associated with misdiagnosis and delayed treatment.